Enovis CORP annual report, FY2016

Business Context and Reporting Period

The supplied filing is Colfax Corporation’s Form 10-K for the fiscal year ended December 31, 2016, filed February 14, 2017. The request metadata identifies Enovis CORP, but the filing itself identifies Colfax Corporation; this entity mismatch should be verified. Colfax operated through Gas and Fluid Handling and Fabrication Technology, serving global industrial, energy, marine, mining, power-generation, welding and cutting markets.

Colfax reported approximately 16,000 employees, with approximately 73% of sales derived from operations outside the United States and approximately 45% shipped to emerging markets. The filing also provides unaudited fourth-quarter 2016 results.

Financial Performance and Key Metrics

Metric20162015Change
Net sales$3.647 billion$3.967 billionDown 8.1%
Gross profit$1.146 billion$1.252 billionDown 8.5%
Gross margin31.4%31.6%Down 20 bps
Operating income$238.0 million$284.6 millionDown 16.4%
Operating margin6.5%7.2%Down 70 bps
Net income attributable to common shareholders$128.1 million$167.7 millionDown 23.6%
Diluted earnings per share$1.04$1.34Down 22.4%
Net cash from operating activities$247.0 million$303.8 millionDown 18.7%
  • Interest expense declined to $30.0 million from $47.7 million, primarily after the 2015 refinancing and lower borrowings.
  • The income-tax provision increased to $62.8 million from $49.7 million. The 2014 comparison included a significant $145.4 million non-cash tax benefit related to deferred tax assets.
  • Cash and cash equivalents were $221.7 million at year-end, up from $197.5 million.
  • Total debt was $1.292 billion, down from $1.418 billion. Approximately $1.286 billion of contractual debt maturities were scheduled for 2020.
  • Capital expenditures were $63.3 million; acquisitions used $26.0 million of cash, primarily for a December 2016 automation acquisition.
  • Gas and Fluid Handling sales were $1.847 billion, with a 9.0% segment operating margin. Fabrication Technology sales were $1.800 billion, with a 10.8% segment operating margin.
  • Fourth-quarter 2016 net sales were $933.8 million and net income attributable to common shareholders was $37.8 million, or $0.31 diluted earnings per share.

Material Changes Versus the Prior Comparable Period

  • Sales declined $320.0 million, reflecting lower volumes in numerous end markets, unfavorable foreign exchange of approximately $149.2 million, and existing-business declines of $223.8 million, partly offset by $52.9 million of acquisition-related sales.
  • Gas and Fluid Handling sales declined 6.8%; its operating margin fell from 9.8% to 9.0%, primarily due to lower volumes, weaker project margins and an asbestos coverage adjustment.
  • Fabrication Technology sales declined 9.3%, but its operating margin increased from 10.0% to 10.8% because of pricing, materials savings and cost controls.
  • Restructuring charges increased to $74.2 million from $61.2 million, while cash restructuring payments were $66.6 million.
  • A Delaware Supreme Court ruling resulted in an $8.2 million reduction to the recoverable asbestos insurance asset. Colfax also recorded a $2.4 million charge related to deconsolidating its Venezuelan operations.
  • Gas and Fluid Handling backlog declined to approximately $1.0 billion from $1.1 billion; most of the backlog was expected to be filled during 2017.
  • Colfax repurchased 1.0 million shares for approximately $20.8 million. The $100 million repurchase authorization expired December 31, 2016. No dividends were paid or expected in the foreseeable future.

Liquidity, Debt, Outlook and Risks

Management stated that available liquidity, including the principal credit facility, was adequate to fund operations for the next twelve months. The revolving credit facility had $859.5 million of availability, and bilateral credit facilities had $165.9 million of unused capacity. Letters of credit outstanding totaled $374.5 million. The company was in compliance with its credit agreement covenants, including a maximum total leverage ratio of 3.5 to 1.0 and minimum interest coverage ratio of 3.0 to 1.0.

Management expected long-term organic growth from broader product offerings, expanded customer coverage and continued application of the Colfax Business System. It also expected continued strategic acquisitions, further cost reductions, asset and back-office rationalization, and manufacturing consolidation. The filing disclosed expected 2017 restructuring charges of approximately $45 million and pension and post-retirement contributions of approximately $30.1 million.

  • Principal operating risks include cyclical industrial demand, lower oil and commodity prices, customer capital-spending reductions, competitive pricing pressure and raw-material costs.
  • Foreign exchange remains significant; management expected currency movements to negatively affect 2017 results. A 10% depreciation in major currencies was estimated to reduce equity by approximately $200 million, net of hedging effects.
  • Approximately $2.6 billion of goodwill and $364.1 million of indefinite-lived trade names remained subject to impairment testing. No goodwill impairment was recorded, but the Air and Gas Handling reporting unit’s estimated fair value exceeded carrying value by approximately 12%, indicating sensitivity to further deterioration.
  • Asbestos liabilities and insurance recoveries remain material and dependent on claim frequency, settlement costs, insurer solvency and ongoing litigation. Management estimated a 92% recovery rate for one subsidiary’s future asbestos costs and anticipated approximately $73 million of reimbursements for previously funded costs, subject to timing and legal disputes.
  • Defined benefit plans were underfunded by approximately $177.4 million for pension benefits and $26.3 million for other post-retirement benefits.
  • Other risks include international regulatory compliance, sanctions and export controls, cybersecurity, environmental liabilities, product liability, labor relations, tax audits and acquisition integration.

Most Important Facts to Verify

  • Confirm that this Colfax Corporation filing, rather than an Enovis Corporation filing, is the intended source document.
  • Review the full debt agreement, maturity schedule, covenant calculations and refinancing requirements around 2020.
  • Assess the sustainability of earnings and cash flow after excluding restructuring costs, asbestos adjustments, foreign-exchange effects and other unusual items.
  • Validate assumptions supporting goodwill and trade-name valuations, particularly the approximately 12% Air and Gas Handling fair-value cushion.
  • Monitor asbestos claim activity, insurer reimbursements, pending Delaware proceedings and potential cash-funding requirements.
  • Evaluate the effect of continued market weakness, currency movements and customer capital-spending trends on backlog, margins and 2017 results.
  • Review pension funding needs, international cash restrictions, tax contingencies and the $305.4 million of supplier purchase obligations.